| Survivors | Non-survivors | Univariate |
---|---|---|---|
n = 1708 | n = 122 | P value | |
Male | 1187 (69.5) | 92 (75.4) | 0.20 |
Age (y) | 73.2 ± 14.4 | 78.8 ± 10.4 | <0.001 |
Smoking statusa | Â | Â | 0.26 |
 Current | 273 (16.0) | 19 (15.6) |  |
 Past | 780 (45.7) | 68 (55.7) |  |
 Never | 655 (38.3) | 35 (28.7) |  |
Comorbidity | |||
 Chronic heart disease | 509 (29.8) | 45 (36.9) | 0.12 |
 COPDb | 393 (23.0) | 46 (37.7) | <0.001 |
 Diabetes mellitus | 340 (19.9) | 24 (19.7) | 1.00 |
 Cerebrovascular disease | 325 (19.0) | 27 (22.1) | 0.47 |
 Malignancy | 148 (8.7) | 19 (15.6) | 0.02 |
 Chronic kidney disease | 125 (7.3) | 11 (9.0) | 0.47 |
 Chronic liver disease | 100 (5.9) | 10 (8.2) | 0.39 |
Vital signs | Â | Â | Â |
 Body temperature (°C) | 37.9 ± 1.1 | 37.4 ± 1.2 | <0.001 |
 Systolic blood pressure (mmHg) | 129 ± 26 | 126 ± 30 | 0.19 |
 Heart rate (beats/min) | 98 ± 19 | 103 ± 25 | 0.004 |
 Respiratory rate (breaths/min) | 23 ± 7 | 28 ± 9 | <0.001 |
 PaO2/FiO2 ≤ 250 (mmHg)c | 554 (32.4) | 92 (75.4) | <0.001 |
Laboratory examinations | |||
 Alb (g/dL) | 3.2 ± 0.6 | 2.6 ± 0.6 | <0.001 |
 BUN (mg/dL) | 21.8 ± 14.5 | 34.5 ± 22.2 | <0.001 |
 Cr (mg/dL) | 1.01 ± 0.8 | 1.27 ± 1.2 | 0.001 |
 Na (mmol/L) | 136.7 ± 4.2 | 137.2 ± 6.3 | 0.25 |
 Ht (%) | 37.1 ± 5.5 | 35.6 ± 6.5 | 0.004 |
 Plt (×104/μL) | 22.5 ± 10.2 | 22.8 ± 10.2 | 0.75 |
 WBC (×103/μL) | 12.3 ± 6.2 | 12.1 ± 6.4 | 0.75 |
 CRP (mg/L) | 125 ± 94 | 164 ± 108 | <0.001 |
Multilobar pneumonia | 939 (55.0) | 99 (81.1) | <0.001 |
Bacteremia | 73 (4.3) | 20 (16.4) | <0.001 |
β-lactam monotherapy | 1109 (64.9) | 72 (59.0) | 0.22 |
AZM combination | 354 (20.7) | 12 (9.8) | 0.005 |
FQN combination | 81 (4.7) | 30 (24.6) | <0.001 |
MINO combination | 79 (4.6) | 3 (2.5) | 0.37 |
Mechanical ventilation | 99 (5.8) | 40 (32.8) | <0.001 |
Vasopressor drug usage | 60 (3.5) | 26 (21.3) | <0.001 |
ICU admission | 67 (3.9) | 28 (23.0) | <0.001 |
A-DROP (score) | Â | Â | <0.001 |
 0 | 204 (11.9) | 1 (0.8) |  |
 1 | 478 (28.0) | 7 (5.7) |  |
 2 | 545 (31.9) | 28 (23.0) |  |
 3 | 372 (21.8) | 54 (44.3) |  |
 4 | 97 (5.7) | 29 (23.8) |  |
 5 | 12 (0.7) | 3 (2.5) |  |
CURB-65 (score) | Â | Â | <0.001 |
 0 | 192 (11.2) | 0 (0) |  |
 1 | 540 (31.6) | 12 (9.8) |  |
 2 | 594 (34.8) | 39 (32.0) |  |
 3 | 294 (17.2) | 35 (28.7) |  |
 4 | 74 (4.3) | 32 (26.2) |  |
 5 | 14 (0.8) | 4 (3.3) |  |
PSI (score) | 100.7 ± 32.3 | 140.9 ± 37.2 | <0.001 |
PSI (class) | Â | Â | <0.001 |
 I | 36 (2.1) | 0 (0) |  |
 II | 210 (12.3) | 1 (0.8) |  |
 III | 447 (26.2) | 8 (6.6) |  |
 IV | 750 (43.9) | 47 (38.5) |  |
 V | 265 (15.5) | 66 (54.1) |  |
IDSA/ATS severe criteria | Â | Â | <0.001 |
 Yes | 490 (28.7) | 95 (77.9) |  |
 No | 1218 (71.3) | 27 (22.1) |  |